Insight
AI in M&A: 10 Things to Consider in Acquisitions
by Julia Apostle, Alexis Marraud des Grottes and Zac Padgett
9 minute read | September.18.2023

by Julia Apostle, Alexis Marraud des Grottes and Zac Padgett
9 minute read | September.18.2023
by Jamie Moore, Kristy Hart, Alex Sobolev and Anna O'Kelly
9 minute read | September.28.2023
In the fifteenth installment of Orrick's Founder Series, we offer guidance on what founders should look out for when developing or using AI in the UK.
by Harry Clark, Jeanine P. McGuinness and Elizabeth Zane
5 minute read | August.14.2023
by Nicola Whiteley, Emma Zarb, Charlotte Oliver and Heather Hanlon
9 minute read | August.29.2023
by Richard F. Martinelli and Daniel Patrick Kearney
4 minute read | August.03.2023
by Annette Hurst, Daniel Yost, Ramin Tohidi, Sarah Schaedler and Daniel Healow
10 minute read | August.03.2023
by Dr. Daniel Ashkar
2 minute read | September.01.2023
Instructive overview of material GDPR requirements in relation to AI applications as well as related practical guidance (German language article)
by Harry Clark, Jeanine P. McGuinness, Elizabeth Zane, Allison Lofgren Bradham, Maria Sergeyeva and Gregory I. Hume
3 minute read | February.24.2025
by Robert Loeb, Cesar Lopez-Morales, Ed Williams and Ramon J. Ryan
4 minute read | February.07.2025
by Georgia C. Ravitz, Shari Esfahani, Stephen Thau, Thora Johnson, Jeremy D. Sherer and Amy M. Joseph
2 minute read | January.13.2025
The FDA issued draft guidance on assessing AI model credibility for drug safety, effectiveness, and quality in regulatory decisions.
by Dr. Christian Schröder and Tobias Stephan
6 minute read | April.25.2025
The European Commission has recently published its first set of draft guidelines on the practical impact of the AI Act.
by Thora Johnson, Alyssa Wolfington and Michaela Frai
6 minute read | January.27.2025